Попередня Наступна

ПОТОЧНИЙ НОМЕР

№1' 2022p.

ІНФЕКЦІЙНІ ХВОРОБИ
DOI (https://doi.org/10.37436/2308-5274-2022-1-16)

ДО ПРОБЛЕМИ ПРОФІЛАКТИКИ ПОШИРЕННЯ КОРОНАВІРУСНОЇ ХВОРОБИ COVID−19 СЕРЕД ДІТЕЙ І ПІДЛІТКІВ ШКІЛЬНОГО ВІКУ

Доц. О. В. БОБРОВА, проф. Н. Г. МІХАНОВСЬКА, канд. мед. наук К. А. КРИВОНОС, канд. фіз.-мат. наук С. М. ВОРОБЙОВ
Харківський національний університет ім. В. Н. Каразіна, Україна

Розглянуто актуальні проблеми перебігу штаму "Дельта", а також впровадження методів покращення інформованості дітей і підлітків шкільного віку про гігієнічні навички та профілактику захворювання на коронавірусну інфекцію.

Ключові слова: COVID−19, анкета−опитувальник, діти та підлітки, профілактичні заходи.

ABOUT THE PROBLEM OF PREVENTING THE SPREAD OF COVID−19 CORONAVIRUS DISEASE AMONG CHILDREN AND ADOLESCENTS OF SCHOOL AGE

O. V. BOBROVA, N. G. MIKHANOVSKA, K. A. KRYVONOS, S. M. VOROBYOV

The current problems with the Delta variant, as well as the introduction of the methods to improve the awareness of children and adolescents of school age about hygiene skills and prevention of coronavirus infection have been considered.

Key words: COVID−19, questionnaire, children and adolescents, preventive measures.




REFERENCES


1. This is what Bill Gates had to say about epidemics, back in 2015. URL: https://www.weforum.org/agenda/2020/03/bill−gates−epidemic−pandemic−preparedness−ebola−covid−19

2. British Paediatric Society. Guidance for the clinical management of children admitted to hospital with suspected COVID−19. URL: https://www.rcpch.ac.uk/sites/default/files/2020−03/bprs_management_of_children_admitted_to_hospital_with_covid19_−_20200319.pdf

3. World Health Organization (WHO). COVID−19 Clinical management: living guidance, 25.01.2021. URL: https://www.who.int/publications/i/item/WHO−2019−nCoV−clinical−2021−1

4. World Health Organization (WHO). Tackling antimicrobial resistance in the COVID−19 pandemic. URL: https://www.who.int/bulletin/volumes/98/7/20−268573/en/#:~:text=The%20guidance%20does%20not%20recommend,of%20a%20bacterial%20infection%20exist.

5. The Management of Community−Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America. URL: https://academic.oup.com/cid/article/53/7/e25/424286#74161858

6. Analysis of the Delta Variant B.1.617.2 COVID−19 / Shayan Shiehzadegan, Nazanin Alaghemand, Michael Fox, Vishwanath Venketaraman. Clin. Pract. 2021. Vol. 11 (4). P. 778−784. doi: 10.3390/clinpract11040093PMCID: PMC8544471

7. Recommandations pour le traitement des enfants atteints de COVID−19 Belgian Pediatric Covid−19 Task Force (Adaptation du protocole original de la KULeuven. URL: http://gbs−vbs.org/fileadmin/user_upload/Unions/PED/Belg_Recomm_COVID_ped_31mar_FR.pdf

8. Fusiono fintelligent learning for COVID−19: Astate−of−the−art review and analysis on real medical data / D. Weiping et al. Neurocomputing. 2021. № 457. R. 40−66

9. Centers for Disease Control and Prevention (CDC). Multisystem Inflammatory Syndrome in Children (MIS−C) Associated with Coronavirus Disease 2019 (COVID−19).

10. American College of Rheumatology. Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS−C) Associated with SARS−CoV−2 and Hyperinflammation in COVID−19. URL: https://www.rheumatology.org/Portals/0/Files/ACR−COVID−19−Clinical−Guidance−Summary−MIS−C−Hyperinflammation.pdf

11. Operativna іnformatsіya pro poshirennya ta profіlaktiku COVID−19. URL: https://moz.gov.ua/article/news/operativna−informacija−pro−poshirennja−koronavirusnoi−infekcii−2019−cov19

12. U. S. Food and Drug Administration (FDA) Expanded Access. URL: https://www.fda.gov/news−events/public−health−focus/expanded−access

13. URL: https://www.doh.wa.gov/Emergencies/COVID19/Vaccine Information/VaccineBoosterDoses

14. Genomic−informed pathogen surveillance in Africa: opportunities and challenges / S. C. Inzaule et al. Lancet Infect Dis. 2021. № 21. e281−e289. doi: 10.1016/S1473−3099(20)30939−7

15. Emergence of new SARS−CoV−2 Variant of Concern Omicron (B.1.1.529) − highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID−19 response and control efforts 3 / E. Petersen et al. Int. J. Infect. Dis. 2021. № 114. P. 268−272. doi: 10.1016/j.ijid.2021.11.040

16. Infections Diseases Society of America. IDSA Guidelines on the Treatment and Management of Patients with COVID−19. URL: https://www.idsociety.org/practice−guideline/covid−19−guideline−treatment−and−management

17. Nakaz MOZ Ukraїni vіd № 2234 13.10.2021 "Pro vvedennya v dіyu Rіshennya operativnogo shtabu Mіnіsterstva okhoroni zdorov'ya Ukraїni z reaguvannya na situatsії z poshirennya іnfektsіinikh khvorob, yakim mozhna zapobіgti shlyakhom vaktsinatsії vіd 01 zhovtnya 2021 roku". URL: https://thepharma.media/uk/law−database/3301−nakaz−moz−ukrayini−vid−13102021−2234

18. National Institute for Health and Care Excellence (NICE). COVID−19 rapid guideline: Managing COVID−19. URL: https://app.magicapp.org/#/guideline/L4Qb5n/section/jb45gn

19. Yak navchiti uchnіv vіdrіznyati feiki vіd pravdi. URL: https://www.unicef.org/ukraine/media/12736/file



Завантажити статтю в форматі PDF (138 KB)
Наверх